Thrombolysis in acute ischemic stroke with vitreous hemorrhage.
Moudgil
Shyam S
SS
D000208:Acute Disease / Q000628:therapy; D000368:Aged; D001766:Blindness / Q000139:chemically induced / Q000517:prevention & control; D002545:Brain Ischemia / Q000150:complications / Q000628:therapy*; D002985:Clinical Protocols; D000075202:Contraindications; D004632:Emergency Medical Services / Q000379:methods / Q000592:standards; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000592:standards; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control; D007275:Injections, Intravenous / Q000009:adverse effects / Q000592:standards; D008297:Male; D018570:Risk Assessment; D020521:Stroke / Q000150:complications / Q000628:therapy*; D017131:Thrombectomy / Q000379:methods / Q000592:standards; D015912:Thrombolytic Therapy / Q000379:methods* / Q000592:standards; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D014656:Vascular Surgical Procedures / Q000379:methods / Q000592:standards; D014823:Vitreous Hemorrhage / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator